Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB with Adjuvants in Lumbar Spine Fusion
NCT06658054Phase 4Not yet recruiting
- Sponsor
- University of Southern California
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and dexamethasone in postoperative pain (2 arms), sponsored by University of Southern California. Primary endpoint: Postoperative opioid consumption. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
dexmedetomidinedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06658054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06658054.